niacinamide and tyrphostin ag 1024

niacinamide has been researched along with tyrphostin ag 1024 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baradari, V; Höpfner, M; Huether, A; Scherübl, H; Schuppan, D	1

Other Studies

1 other study(ies) available for niacinamide and tyrphostin ag 1024

Article	Year
Sorafenib alone or as combination therapy for growth control of cholangiocarcinoma. Biochemical pharmacology, 2007, May-01, Volume: 73, Issue:9 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzenesulfonates; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; Cholangiocarcinoma; Enzyme Activation; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Niacinamide; Phenylurea Compounds; Pyridines; Receptor, IGF Type 1; Sorafenib; Tumor Cells, Cultured; Tyrphostins	2007

Article

Year

Sorafenib alone or as combination therapy for growth control of cholangiocarcinoma.

Biochemical pharmacology, 2007, May-01, Volume: 73, Issue:9

Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzenesulfonates; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; Cholangiocarcinoma; Enzyme Activation; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Niacinamide; Phenylurea Compounds; Pyridines; Receptor, IGF Type 1; Sorafenib; Tumor Cells, Cultured; Tyrphostins

2007